Analysts predict that Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) will report $121.56 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Sabra Healthcare REIT’s earnings, with estimates ranging from $108.97 million to $145.21 million. Sabra Healthcare REIT posted sales of $61.93 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 96.3%. The company is expected to issue its next quarterly earnings report after the market closes on Wednesday, November 1st.

On average, analysts expect that Sabra Healthcare REIT will report full-year sales of $121.56 million for the current year, with estimates ranging from $375.40 million to $414.42 million. For the next financial year, analysts forecast that the business will report sales of $629.13 million per share, with estimates ranging from $615.84 million to $635.90 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Sabra Healthcare REIT.

A number of research analysts have commented on SBRA shares. Cantor Fitzgerald restated a “buy” rating and set a $30.00 price target on shares of Sabra Healthcare REIT in a research note on Friday, September 8th. SunTrust Banks, Inc. restated a “buy” rating and set a $30.00 price target on shares of Sabra Healthcare REIT in a research note on Monday, October 9th. Capital One Financial Corporation started coverage on shares of Sabra Healthcare REIT in a research note on Monday, September 25th. They set an “equal weight” rating and a $24.00 price target for the company. Zacks Investment Research upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, BidaskClub cut shares of Sabra Healthcare REIT from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $25.30.

TRADEMARK VIOLATION NOTICE: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/10/30/sabra-healthcare-reit-inc-sbra-expected-to-announce-quarterly-sales-of-121-56-million.html.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Arizona State Retirement System increased its holdings in shares of Sabra Healthcare REIT by 0.3% during the second quarter. Arizona State Retirement System now owns 34,096 shares of the real estate investment trust’s stock worth $822,000 after buying an additional 100 shares in the last quarter. Amalgamated Bank increased its holdings in shares of Sabra Healthcare REIT by 1.8% during the second quarter. Amalgamated Bank now owns 8,880 shares of the real estate investment trust’s stock worth $214,000 after buying an additional 159 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Sabra Healthcare REIT by 9.3% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,151 shares of the real estate investment trust’s stock worth $100,000 after buying an additional 352 shares in the last quarter. Advisors Asset Management Inc. increased its holdings in shares of Sabra Healthcare REIT by 1.9% during the second quarter. Advisors Asset Management Inc. now owns 20,024 shares of the real estate investment trust’s stock worth $483,000 after buying an additional 382 shares in the last quarter. Finally, Texas Permanent School Fund increased its holdings in shares of Sabra Healthcare REIT by 0.8% during the second quarter. Texas Permanent School Fund now owns 47,667 shares of the real estate investment trust’s stock worth $1,149,000 after buying an additional 400 shares in the last quarter. 99.26% of the stock is owned by institutional investors.

Sabra Healthcare REIT (NASDAQ:SBRA) opened at 20.53 on Monday. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 17.28 and a beta of 0.88. Sabra Healthcare REIT has a 12-month low of $19.30 and a 12-month high of $29.10. The stock’s 50 day moving average price is $21.82 and its 200 day moving average price is $23.44.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc is a real estate investment trust. The Company, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company’s segment includes investments in healthcare-related real estate properties. The Company’s primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector.

Get a free copy of the Zacks research report on Sabra Healthcare REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Healthcare REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Healthcare REIT Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT Inc. and related companies with MarketBeat.com's FREE daily email newsletter.